Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on LNTH stock, giving a Buy rating yesterday.Stay Ahead of the ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as a BMI of 30 or more.

A new study reveals that over 75% of older adults with dementia may not know they have the disease, with awareness rates even ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what ...

New expensive but disease-modifying treatments are expected to foster Alzheimer’s disease market growth globally, according ...

The Tennessee Lady Volunteers are set to host its annual “We Back Pat” game at Food City Center on Thursday against Mississippi State.

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...